JP2001509782A5 - - Google Patents

Download PDF

Info

Publication number
JP2001509782A5
JP2001509782A5 JP1997538862A JP53886297A JP2001509782A5 JP 2001509782 A5 JP2001509782 A5 JP 2001509782A5 JP 1997538862 A JP1997538862 A JP 1997538862A JP 53886297 A JP53886297 A JP 53886297A JP 2001509782 A5 JP2001509782 A5 JP 2001509782A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997538862A
Other languages
English (en)
Japanese (ja)
Other versions
JP4309473B2 (ja
JP2001509782A (ja
Filing date
Publication date
Priority claimed from US08/637,968 external-priority patent/US5608095A/en
Application filed filed Critical
Publication of JP2001509782A publication Critical patent/JP2001509782A/ja
Publication of JP2001509782A5 publication Critical patent/JP2001509782A5/ja
Application granted granted Critical
Publication of JP4309473B2 publication Critical patent/JP4309473B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53886297A 1996-04-30 1997-03-03 抗アテローム性動脈硬化剤としてのアルキル―4―シリル―フェノールおよびそのエステル Expired - Fee Related JP4309473B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/637,968 1996-04-30
US08/637,968 US5608095A (en) 1996-04-30 1996-04-30 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
PCT/US1997/003335 WO1997041129A1 (en) 1996-04-30 1997-03-03 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents

Publications (3)

Publication Number Publication Date
JP2001509782A JP2001509782A (ja) 2001-07-24
JP2001509782A5 true JP2001509782A5 (cg-RX-API-DMAC10.html) 2004-12-02
JP4309473B2 JP4309473B2 (ja) 2009-08-05

Family

ID=24558107

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53886297A Expired - Fee Related JP4309473B2 (ja) 1996-04-30 1997-03-03 抗アテローム性動脈硬化剤としてのアルキル―4―シリル―フェノールおよびそのエステル

Country Status (19)

Country Link
US (1) US5608095A (cg-RX-API-DMAC10.html)
EP (1) EP0900225B1 (cg-RX-API-DMAC10.html)
JP (1) JP4309473B2 (cg-RX-API-DMAC10.html)
KR (1) KR100503181B1 (cg-RX-API-DMAC10.html)
CN (1) CN1216993A (cg-RX-API-DMAC10.html)
AR (1) AR006890A1 (cg-RX-API-DMAC10.html)
AT (1) ATE212639T1 (cg-RX-API-DMAC10.html)
AU (1) AU711322B2 (cg-RX-API-DMAC10.html)
BR (1) BR9709190A (cg-RX-API-DMAC10.html)
CA (1) CA2251991C (cg-RX-API-DMAC10.html)
DE (1) DE69710191T2 (cg-RX-API-DMAC10.html)
DK (1) DK0900225T3 (cg-RX-API-DMAC10.html)
ES (1) ES2167716T3 (cg-RX-API-DMAC10.html)
IL (1) IL126758A0 (cg-RX-API-DMAC10.html)
NO (1) NO985039L (cg-RX-API-DMAC10.html)
PT (1) PT900225E (cg-RX-API-DMAC10.html)
TW (1) TW474940B (cg-RX-API-DMAC10.html)
WO (1) WO1997041129A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA973503B (cg-RX-API-DMAC10.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2252869A1 (en) * 1996-04-30 1997-11-06 Hoechst Marion Roussel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
US5795876A (en) * 1996-04-30 1998-08-18 Hoechst Marion Rousssel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
TR199902802T2 (xx) 1997-05-14 2000-04-21 Atherogenics, Inc. Kardiyovask�ler hastal�klar ve enflamatuar hastal�klar�n tedavisi i�in probukol monoesterleri.
US6121463A (en) * 1997-06-24 2000-09-19 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
JP2002506443A (ja) * 1997-06-25 2002-02-26 アベンティス・ファーマスーティカルズ・インコーポレイテッド 2,6−ジ−t−ブチル−4−[(ジメチル−4−メトキシフェニルシリル)メチルオキシ]フェノール及び2,6−ジ−t−ブチル−4−[(ジメチル−2−メトキシフェニルシリル)メチルオキシ]フェノール
KR20010020611A (ko) * 1997-07-01 2001-03-15 아테로제닉스, 인코포레이티드 항산화제에 의한 과증식질병 치료의 향상
WO2000028332A1 (en) * 1998-11-09 2000-05-18 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels
US6887712B1 (en) 1998-11-09 2005-05-03 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels
US6020383A (en) * 1999-01-11 2000-02-01 Eastman Chemicals Company Method for reducing blood cholesterol and/or blood triglycerides
WO2002040021A2 (en) 2000-11-17 2002-05-23 Idenix (Cayman) Limited Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
WO2002087556A2 (en) * 2001-04-11 2002-11-07 Atherogenics, Inc. Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
WO2003039231A2 (en) * 2001-10-25 2003-05-15 Atherogenics, Inc. Compounds and methods for treating transplant rejection
JP2006506314A (ja) * 2001-11-09 2006-02-23 アセロジエニクス・インコーポレイテツド 心血管疾患の逆転及び予防方法
RU2004121898A (ru) * 2001-12-19 2006-01-20 Атеродженикс, Инк. (Us) Производные халкона и их применение для лечения заболеваний
US6960683B2 (en) * 2002-07-12 2005-11-01 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
AU2003266165A1 (en) * 2002-09-13 2004-04-30 Hossein Dovlatabadi Methods and compositons for the use of d-malic acid to decrease serum triglyceride, cholesterol, and lipoprotein levels
US20040181075A1 (en) * 2002-12-19 2004-09-16 Weingarten M. David Process of making chalcone derivatives
CA2512980A1 (en) * 2003-01-13 2004-07-29 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
US7173129B2 (en) * 2003-06-06 2007-02-06 Athero Genics, Inc. Sulfonamide-substituted chalcone derivatives and their use to treat diseases
JP2007509054A (ja) * 2003-10-17 2007-04-12 アミリン・ファーマシューティカルズ,インコーポレイテッド 血管健康を促進するシリルフェノール
WO2005102323A2 (en) 2004-04-20 2005-11-03 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
WO2005112914A2 (en) 2004-04-20 2005-12-01 Atherogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
US20060063828A1 (en) * 2004-06-28 2006-03-23 Weingarten M D 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
US20060058268A1 (en) * 2004-07-01 2006-03-16 Sundell Cynthia L Compounds and methods for treating diabetic vascular diseases
BRPI0809423A2 (pt) * 2007-03-26 2014-09-09 Salutria Pharmaceuticals Llc Usos e composições de derivados de probucol para o tratamento de diabetes
WO2008118946A1 (en) * 2007-03-27 2008-10-02 Atherogenics, Inc. Methods and compositions using certain phenolic derivatives for the treatment of diabetes
BR112012025343A2 (pt) * 2010-04-15 2016-06-28 Merck Patent Gmbh processo para a preparação de hidroquinonas
CN109641004A (zh) * 2016-07-08 2019-04-16 燕财成有限公司 实体癌治疗剂

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3129262A (en) * 1962-10-08 1964-04-14 Consolidation Coal Co Reduction of organic thiocyanates
US3862332A (en) * 1967-05-11 1975-01-21 Dow Chemical Co Method of lowering serum cholesterol
US3576883A (en) * 1969-06-30 1971-04-27 Consolidation Coal Co Alkylidenedithiobisphenols
US3786100A (en) * 1971-12-10 1974-01-15 Continental Oil Co Keto substituted alkylidenedithiobisphenols
US3897500A (en) * 1971-12-10 1975-07-29 Continental Oil Co Alkylidenedithiobisphenols
JPS61263988A (ja) * 1985-05-16 1986-11-21 Shionogi & Co Ltd シリル置換エ−テル類および殺虫・殺ダニ剤
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US4719237A (en) * 1986-01-28 1988-01-12 Merrell Dow Pharmaceuticals Inc. Cardiac antiarrythmic method employing probucol
US4734527A (en) * 1986-10-17 1988-03-29 Merrell Dow Pharmaceuticals Inc. Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol
US4772363A (en) * 1987-01-14 1988-09-20 Merrell Dow Pharmaceuticals Inc. Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol by electrocatalysis
US4861443A (en) * 1987-01-14 1989-08-29 Merrell Dow Pharmaceuticals Inc. Process for preparing 4,4'-isopropylidenedithio-bis-(2,6-di-tertiarybutylphenol) by electrocatalysis
US5401883A (en) * 1987-01-20 1995-03-28 Merrell Dow Pharmaceuticals Inc. Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol and 4,4'-isopropylidenedithio-bis-(2,6-di-tertiarybutylphenol)
US4975467A (en) * 1987-03-17 1990-12-04 Merrell Dow Pharmaceuticals Inc. Method of inhibiting interleukin-1 release and alleviating interleukin-1 mediated conditions
JPH0813824B2 (ja) * 1988-10-27 1996-02-14 北興化学工業株式会社 有機ケイ素化合物
US4900757A (en) * 1988-12-08 1990-02-13 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane
US5047555A (en) * 1988-12-13 1991-09-10 Tanabe Seiyaku Co., Ltd. 4-aminophenol derivatives and processes for preparing the same
US5217870A (en) * 1989-04-28 1993-06-08 Biogen, Inc. Monoclonal antibodies against CDX
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US5008421A (en) * 1989-07-05 1991-04-16 Aristech Chemical Corporation Silyl derivatives of 2,6-dimethyl-4-allyl phenol
DE3935638A1 (de) * 1989-10-26 1991-05-02 Consortium Elektrochem Ind Organosilylalkylaromaten
US5061734A (en) * 1990-05-09 1991-10-29 Merrell Dow Pharmaceuticals Inc. Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
US5112870A (en) * 1990-05-09 1992-05-12 Merrell Dow Pharmaceuticals Inc. Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
JP2899064B2 (ja) * 1990-05-23 1999-06-02 キヤノン株式会社 液晶性化合物、これを含む液晶組成物およびこれを使用した液晶素子
US5155250A (en) * 1990-07-05 1992-10-13 Merrell Dow Pharmaceuticals Inc. 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents
US5304668A (en) * 1990-07-05 1994-04-19 Merrell Dow Pharmaceuticals Bis-[4-(2,6-di-alkyl)phenolisilane derivatives as antiatherosclerotic agents
NZ238807A (en) * 1990-07-05 1994-03-25 Merrell Dow Pharma Bis[4-(2,6-dialkyl)phenol]silane derivatives and antiatherosclerotic compositions
US5254549A (en) * 1991-12-19 1993-10-19 Merz & Co. Gmbh & Co. New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
ATE231915T1 (de) * 1992-09-02 2003-02-15 Isis Pharmaceuticals Inc Beeinflussing der zelladhäsie durch oligonukleotide
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
EP0670735B1 (en) * 1992-11-13 1997-04-02 Board Of Regents Of The University Of Washington Peripheralization of hematopoietic stem cells
EP0675883A1 (en) * 1992-12-22 1995-10-11 Smithkline Beecham Plc Piperidine derivatives as calcium channel antagonists
ATE182625T1 (de) * 1993-01-12 1999-08-15 Biogen Inc Rekombinante anti-vla4 antikörpermoleküle
JP3593343B2 (ja) * 1993-02-09 2004-11-24 バイオジェン インコーポレイテッド インシュリン依存型糖尿病の治療
WO1995004749A1 (en) * 1993-08-05 1995-02-16 Isis Pharmaceuticals, Inc. Oligomers for modulating metabolic function
JP3650144B2 (ja) * 1994-06-08 2005-05-18 花王株式会社 細胞接着抑制剤

Similar Documents

Publication Publication Date Title
JP2000502280A5 (cg-RX-API-DMAC10.html)
JP2000506431A5 (cg-RX-API-DMAC10.html)
JP2001503856A5 (cg-RX-API-DMAC10.html)
JP2000501771A5 (cg-RX-API-DMAC10.html)
JP2000501599A5 (cg-RX-API-DMAC10.html)
JP2002513378A5 (cg-RX-API-DMAC10.html)
JP2000500076A5 (cg-RX-API-DMAC10.html)
JP2001507761A5 (cg-RX-API-DMAC10.html)
JP2000513536A5 (cg-RX-API-DMAC10.html)
JP2002512554A5 (cg-RX-API-DMAC10.html)
JP2001525707A5 (cg-RX-API-DMAC10.html)
JP2000502472A5 (cg-RX-API-DMAC10.html)
JP2000501825A5 (cg-RX-API-DMAC10.html)
JP2001524277A5 (cg-RX-API-DMAC10.html)
JP2000505084A5 (cg-RX-API-DMAC10.html)
JP2000502485A5 (cg-RX-API-DMAC10.html)
JP2000502425A5 (cg-RX-API-DMAC10.html)
JP2000502568A5 (cg-RX-API-DMAC10.html)
JP2001501584A5 (cg-RX-API-DMAC10.html)
JP2000501774A5 (cg-RX-API-DMAC10.html)
JP2000502570A5 (cg-RX-API-DMAC10.html)
JP2000501876A5 (cg-RX-API-DMAC10.html)
JP2000501744A5 (cg-RX-API-DMAC10.html)
JP2001509782A5 (cg-RX-API-DMAC10.html)
JP2000512406A5 (cg-RX-API-DMAC10.html)